Related Experiment Video
Updated: Dec 6, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
Viviane Ponath1, Miriam Frech2, Mathis Bittermann1
1Institute for Tumor Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University of Marburg, Hans-Meerwein-Strasse 3, 35043 Marburg, Germany.
Abstract:
Drugs targeting epigenetic mechanisms such as histone deacetylase inhibitors (HDACi) suppress tumor growth. HDACi also induce the expression of ligands for the cytotoxicity receptor NKG2D rendering tumors more susceptible to natural killer (NK) cell-dependent killing. The major acetylases responsible for the expression of NKG2D ligands (NKG2D-L) are CBP and p300. The role of the oncogene and transcriptional repressor SKI, an essential part of an HDAC-recruiting co-repressor complex, which competes with CBP/p300 for binding to SMAD3 in TGFβ signaling, is unknown. Here we show that the siRNA-mediated downregulation of SKI in the pancreatic cancer cell lines Panc-1 and Patu8988t leads to an increased target cell killing by primary NK cells. However, the higher cytotoxicity of NK cells did not correlate with the induction of NKG2D-L. Of note, the expression of NKG2D-L and consequently NK cell-dependent killing could be induced upon LBH589 (LBH, panobinostat) or valproic acid (VPA) treatment irrespective of the SKI expression level but was significantly higher in pancreatic cancer cells upon genetic ablation of SKI. These data suggest that SKI represses the inducible expression of NKG2D-L. The combination of HDACi with NK cell-based immunotherapy is an attractive treatment option for pancreatic tumors, specifically for patients with high SKI protein levels.
Insights
Downregulating the SKI oncogene in pancreatic cancer enhances natural killer (NK) cell killing. SKI represses NKG2D ligand expression, suggesting a combination therapy for pancreatic tumors with high SKI levels.
Area of Science:
- Oncology
- Immunology
- Epigenetics
Background:
- Histone deacetylase inhibitors (HDACi) suppress tumor growth and enhance NK cell cytotoxicity by increasing NKG2D ligand (NKG2D-L) expression.
- CBP and p300 are key acetylases for NKG2D-L expression.
- The role of the oncogenic transcriptional repressor SKI in this process is unknown.
Purpose of the Study:
- To investigate the role of SKI in regulating NKG2D-L expression and NK cell-mediated cytotoxicity in pancreatic cancer.
- To determine if SKI impacts the efficacy of HDACi in enhancing anti-tumor immunity.
Main Methods:
- siRNA-mediated downregulation of SKI in pancreatic cancer cell lines (Panc-1, Patu8988t).
- Assessment of NK cell-mediated cytotoxicity against SKI-depleted or control cells.
- Analysis of NKG2D-L expression following SKI manipulation and/or HDACi treatment (LBH589, VPA).
Main Results:
- Downregulation of SKI increased pancreatic cancer cell killing by primary NK cells.
- This enhanced cytotoxicity did not correlate with increased NKG2D-L expression.
- HDACi treatment induced NKG2D-L and NK cell killing independently of SKI levels.
- Genetic ablation of SKI significantly enhanced NKG2D-L induction by HDACi.
Conclusions:
- SKI acts as a repressor of inducible NKG2D-L expression in pancreatic cancer cells.
- Targeting SKI in combination with HDAC inhibitors may represent a novel therapeutic strategy for pancreatic cancer, particularly in patients with high SKI expression.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

